These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26204275)

  • 21. Screening for lung cancer: for patients at increased risk for lung cancer, it works.
    Jett JR; Midthun DE
    Ann Intern Med; 2011 Oct; 155(8):540-2. PubMed ID: 21893615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST).
    Kramer BS; Berg CD; Aberle DR; Prorok PC
    J Med Screen; 2011; 18(3):109-11. PubMed ID: 22045816
    [No Abstract]   [Full Text] [Related]  

  • 23. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
    Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
    Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed tomography screening for lung cancer.
    Boiselle PM
    JAMA; 2013 Mar; 309(11):1163-70. PubMed ID: 23512063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
    Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
    EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort.
    Krabbe LM; Svatek RS; Shariat SF; Messing E; Lotan Y
    Urol Oncol; 2015 Feb; 33(2):65.e19-25. PubMed ID: 25044253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases.
    Yip R; Henschke CI; Yankelevitz DF; Smith JP
    Radiology; 2014 Nov; 273(2):591-6. PubMed ID: 24955929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective dose assessment for participants in the National Lung Screening Trial undergoing posteroanterior chest radiographic examinations.
    Kruger R; Flynn MJ; Judy PF; Cagnon CH; Seibert JA
    AJR Am J Roentgenol; 2013 Jul; 201(1):142-6. PubMed ID: 23789668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial.
    Robertson SE; Joyce NR; Steingrimsson JA; Stuart EA; Aberle DR; Gatsonis CA; Dahabreh IJ
    JAMA Netw Open; 2024 Jan; 7(1):e2346295. PubMed ID: 38289605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.
    Black WC
    J Thorac Imaging; 2015 Mar; 30(2):79-87. PubMed ID: 25635704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model.
    Han SS; Erdogan SA; Toumazis I; Leung A; Plevritis SK
    Cancer Causes Control; 2017 Sep; 28(9):947-958. PubMed ID: 28702814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
    Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
    Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung cancer screening trials: the United States and beyond.
    Jacobson FL; Jaklitsch MT
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S3-6. PubMed ID: 22676977
    [No Abstract]   [Full Text] [Related]  

  • 35. Application of risk prediction models to lung cancer screening: a review.
    Tammemägi MC
    J Thorac Imaging; 2015 Mar; 30(2):88-100. PubMed ID: 25692785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for lung cancer: it works, but does it really work?
    Silvestri GA
    Ann Intern Med; 2011 Oct; 155(8):537-9. PubMed ID: 21893614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.
    Gohagan J; Marcus P; Fagerstrom R; Pinsky P; Kramer B; Prorok P;
    Chest; 2004 Jul; 126(1):114-21. PubMed ID: 15249451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung Cancer Screening With Low-Dose CT in the United States.
    Eberth JM
    J Am Coll Radiol; 2015 Dec; 12(12 Pt B):1395-402. PubMed ID: 26614885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening.
    Howard DH; Richards TB; Bach PB; Kegler MC; Berg CJ
    Cancer; 2015 Dec; 121(24):4341-7. PubMed ID: 26372542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.